Global Hepatitis C Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Hepatitis C Market Expected To Become By 2029 Compared With Its 2025 Level?

The hepatitis c market size has seen swift expansion in recent years. It is anticipated to increase from $67.17 billion in 2024 to $75.72 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be ascribed to elements such as blood transfusion practices, injection drug use, the scarcity of treatment alternatives, and the introduction of direct-acting antivirals (DaaS).

The hepatitis c market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $132.21 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.0%. Factors contributing to this growth during the forecast period include global initiatives for elimination, enhancements in testing and screening procedures, increased expenditure on healthcare, the incorporation of telemedicine, and the development of novel therapeutic combinations. Key trends identified for the forecast period encompass the availability of accessible and affordable treatments, a sharpened focus on high-risk populations, advancements in drug formulations, increased collaborative efforts and partnerships, and the wider adoption of telehealth and digital solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Which Industry Drivers Are Expected To Accelerate The Hepatitis C Market From 2025 To 2029?

The growth of the hepatitis C market is projected to be driven by an uptick in viral infections. Viral infections are defined as ailments caused by a virus within the body. Treatment for Hepatitis C diminishes viral infection by eliminating the virus and restoring the immune system’s function in patients once the viral load is cleared. As an illustration, in August 2024, the Centers for Disease Control and Prevention, a US-based public health agency, reported that the proportion of individuals with Parvovirus B19, a seasonal respiratory viral infection, rose across all age groups, increasing from 3% between 2022–2024 to 10% by June 2024; the most substantial increase was noted in children aged 5–9 years, where prevalence escalated from 15% during 2022–2024 to 40% by June 2024. Additionally, the percentage of pooled samples containing parvovirus B19 DNA levels markedly grew from 1.5% in December 2023 to 19.9% in June 2024. Thus, the escalating incidence of viral infections is stimulating the hepatitis C market.

What Are The Emerging Segments Gaining Attention In The Hepatitis C Market?

The hepatitis cmarket covered in this report is segmented –

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types

2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments

3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies

5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6

2) By Acute Hepatitis C: Symptomatic; Asymptomatic

3) By Other Types: Mixed Infections; Superinfection

What Key Innovation Trends Are Fueling Advancements In The Hepatitis C Market?

A significant trend gaining prominence in the hepatitis C market involves advancements in diagnostic technologies for hepatitis C. Major companies operating within the hepatitis C market are embracing new technologies to uphold their market position. For example, in July 2022, F. Hoffmann-La Roche Ltd., a pharmaceutical and diagnostics company based in Switzerland, released its Elecsys HCV Duo immunoassay in regions that accept the CE Mark. This Elecsys HCV Duo immunoassay enables the independent and simultaneous determination of hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. The test is capable of identifying patients who are recovering from or displaying symptoms of a chronic infection, which might lead to other conditions such as liver cancer and various early-stage diseases.

Who Are The Major Companies Operating In The Hepatitis C Market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Region Is Projected To Lead The Hepatitis C Market During The Forecast Period?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Hepatitis C Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Market 2025, By The Business Research Company

Hepatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Non Alcoholic Steatohepatitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795